7 May 2021PatentsAlex Baldwin

US backs COVID IP waiver - Industry reacts

After months of open letters and petitions from various sources, the US government has decided to throw its support behind waiving IP rights for COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Biden backs TRIPS waiver for COVID-19 vaccines

6 May 2021 President Joe Biden has backed the waiving of IP rights for COVID-19 vaccines following mounting pressure from countries, charities and industry bodies.

Patents

LSPN Connect: will nationalism block access to a COVID-19 vaccine?

20 October 2020 As scientists around the globe race to find a vaccine for COVID-19, the big question for many is whether competition between nation-states will interfere with citizens’ access to these life-saving treatments.

UK-India trade deal is ‘missed opportunity’, say industry bodies

SEPs now searchable on WIPO’s global patent database

INTA 2025: San Diego to host largest post-COVID Annual Meeting

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Cahill expands practice with three-partner team from King & Spalding

US backs COVID IP waiver - Industry reacts

More on this story

Editor's picks

Editor's picks

More articles